Celyad Oncology’s $25 Million At The Market Offering

CMS Belgium, together with Harvest Law, assisted Celyad Oncology on the deal. Celyad Oncology, a Belgian biotech company listed on Euronext Brussels/Paris and on the Nasdaq…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Paolo Bossi

This content is for Standard 1 Year members only.
Login Join Now